Skip to content
Recall Observatory FDA recall evidence

Drug product

Bupivacaine Hydrochloride in 8.25% Dextrose Injection, USP Spinal 0.75% (15 mg/2 mL) 10 x 2 mL single-dose ampules, Rx only, Manufactured for: Baxter Healthcare Corporation Deerfield, IL 60015 USA, Manufactured by: Baxter Pharmaceuticals India Private Ltd Ahmedabad 382213 India, NDC 36000-092-10

D-0076-2021

October 07, 2020

Class II

Product summary

Firm
Baxter Healthcare Corporation
Event
Event 86529
Status
Terminated
Classification
Class II
Quantity
Unavailable
Official record key
drug-enforcement:D-0076-2021

Official wording

Reason: Presence of particulate matter in solution - black and transparent particles

Code information: Lot #: A0B1241, Exp 10/2020; A0C0091, Exp 12/2020; A0D0268, Exp 02/2022

Distribution pattern: Nationwide USA

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    particulate matter